Bacille Calmette-Guerin immunotherapy of viral warts.

Intralesional immunotherapy with Bacille Calmette-Guerin (BCG) vaccine for the treatment of warts: case report and systematic review

Bacille-Calmette-Guerin non-responders: how to manage

Intravesical immunotherapy with bacille-Calmette-Guerin (BCG) is indicated in the treatment of high-risk and intermediate-risk non-muscle invasive bladder cancer (NMIBC). Our goal is to describe the various disease states following induction and maintenance BCG and to describe contemporary treatment options and the current and projected clinical trial landscape for patients who recur following ...

Author's response to reviews The benefits and risks of bacille Calmette-Guerin vaccination among infants at high risk for both Title: tuberculosis and severe combined immunodeficiency: assessment by Markov model Authors:

The benefits and risks of bacille Calmette-Guerin vaccination among infants at high risk for both Title: tuberculosis and severe combined immunodeficiency: assessment by Markov model

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.

Sequential immunization with mycobacterial antigen Ag85B-expressing DNA and Mycobacterium bovis bacille Calmette-Guerin (BCG) was more effective than BCG immunization in protecting against Mycobacterium tuberculosis infection. Depletion of the CD8(+) T cells in the immunized mice impaired protection in their spleens, indicating that this improved efficacy was partially mediated by CD8(+) T cells.

Osteomyelitis following Bacille Calmette-Guerin vaccination.

Secondary complications after Bacille Calmette-Guerin (BCG) vaccination are unusual. We describe 3 immunocompetent children who developed osteomyelitis after BCG vaccination. The course of the disease is not dramatic, but marked changes are frequently visible in plain radiograph and MRI. The real-time polymerase chain reaction has an essential role to confirm the diagnosis of BCG osteomyelitis....